SCHEMBL715745

SCHEMBL715745

[c]1ccccc1-c1ccc(-c2ccccc2)nn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.44
NPC1 O15118 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
PKM P14618 2/20 0.44
USP2 O75604 1/20 0.44
TP53 P04637 1/20 0.44
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
PBRM1 Q86U86 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CHRNA7 P36544 3/20 0.35
HPGD P15428 1/20 0.35
HTR3A P46098 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
MAPK1 P28482 1/20 0.34
GABRA1 P14867 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1521688 0.80 APLNR (0.31) RAB9ANPC1SMN1; SMN2PKMTP53
SCHEMBL715045 0.78 MEN1 (0.61) RAB9ANPC1SMN1; SMN2PKMTP53
SCHEMBL2493590 0.78 RAB9A (0.62) RAB9ANPC1SMN1; SMN2PKMUSP2
SCHEMBL38086 0.76 LMNA (0.38) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL28590403 0.76 NPC1 (0.39) RAB9ANPC1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL714570 0.76 ASIC3 (0.50) RAB9ANPC1SMN1; SMN2TP53MEN1
SCHEMBL28586219 0.76 HPGDS (0.46) RAB9ANPC1SMN1; SMN2CHRNA7CYP11B1
SCHEMBL41140 0.75 ALDH1A1 (0.42) RAB9ANPC1MEN1KMT2AMAPK1
SCHEMBL38202 0.75 ALDH1A1 (0.42) RAB9ANPC1MEN1KMT2AMAPK1
SCHEMBL9958776 0.74 MEN1 (0.48) RAB9ASMN1; SMN2USP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 RAB9A 440/4885NPC1 2154/4885SMN1; SMN2 4102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.